NCT00858455View on ClinicalTrials.gov

A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Healthy Volunteer
Interventions
DRUG

GSK1349572 and MaaloxAdvanced Maximum Strength

A single dose of GSK1349572 co-administered with a single dose of 20 mL of Maalox Advanced Maximum Strength

DRUG

GSK1349572 and Maalox Advanced Maximum Strength

A single dose of GSK1349572 administered 2 hours prior to administration of a single dose of 20 mL of Maalox Advanced Maximum Strength

DRUG

GSK1349572 and One A Day

A single dose of GSK1349572 50 mg co-administered with a single dose of a One A Day Maximum multivitamin

DRUG

GSK1349572

A single dose of GSK1349572

Trial Locations (1)

14202

GSK Investigational Site, Buffalo

Sponsors

Lead Sponsor

GlaxoSmithKline

Collaborators (1)

Shionogi
All Listed Sponsors
collaborator

Shionogi

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY

NCT00858455 - A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572 | Biotech Hunter | Biotech Hunter